Q: It is obvious to all that the pharmaceutical mobile Internet era has an impact on the current traditional pharmaceutical marketing mode, and how can a pharmaceutical operating company break through the dilemma? When will the administrative provisions of the current pharmaceutical marketing mode on prescription drugs and special drugs, etc. be implemented? Currently policies are falling behind the situation, which will bring large threats to pharmaceutical monitoring. Is it an imitation of the sales model of foreign pharmaceutical Internet?
Shi Lichen: If the pharmaceutical product operating company is a regional company, it shall complete three things as soon as possible: 1. Build a complete B2B platform, which shall be reserved interfaces for docking with other partners; 2. Build a B2C platform together with chain and single pharmacy and even community health care of the service area, and do not attempt to build it alone like Jointown because it is very difficult; 3. Must first learn how to integrate regional resources. The current pharmaceutical commercial distribution will be impacted by the future pharmaceutical e-commerce to be quite disorderly, and the new pharmaceutical commercial pattern with multiple modes and multiple competitive situations will be formed. This pattern will partition the areas and market levels and dock with China's national network, and any pharmaceutical commercial company will become part of it or be eliminated.
